Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure
- PMID: 24025363
- PMCID: PMC3835226
- DOI: 10.1161/JAHA.113.000242
Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure
Abstract
Background: Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described.
Methods and results: We identified 81 874 patients with prevalent heart failure as of January 1, 2010, in a nationally representative 5% sample of Medicare beneficiaries. We classified patients according to enrollment in a Medicare Part D plan as of January 1, 2010. Demographic characteristics, comorbid conditions, and prescriptions were compared by enrollment status. A total of 49 252 (60.2%) were enrolled in a Medicare Part D plan as of January 1. Enrollees were more often women, black, and of lower socioeconomic status. Enrollees with heart failure more often filled prescriptions for loop diuretics than angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β-blockers, or aldosterone antagonists. During the first 4 months of 2010, 5444 (12.3%) reached the coverage gap, and 566 (1.3%) required catastrophic coverage beyond the gap.
Conclusions: Medicare beneficiaries with heart failure differ significantly according to enrollment in Part D prescription drug plans and represent a population underrepresented in clinical efficacy trials. Many face the coverage gap, and few select Medicare Part D plans that provide coverage during the gap. Linking Medicare Part D event data with clinical registries could help to determine whether eligible enrollees are undertreated for heart failure.
Keywords: Medicare Part D; heart failure; outcome assessment (health care).
Similar articles
-
Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.J Manag Care Pharm. 2012 Mar;18(2):106-15. doi: 10.18553/jmcp.2012.18.2.106. J Manag Care Pharm. 2012. PMID: 22380470 Free PMC article.
-
Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure.J Manag Care Spec Pharm. 2019 Jun;25(6):705-713. doi: 10.18553/jmcp.2019.25.6.705. J Manag Care Spec Pharm. 2019. PMID: 31134861 Free PMC article.
-
The Medicare drug benefit (Part D) and treatment of heart failure in older adults.Am Heart J. 2010 Jul;160(1):159-65. doi: 10.1016/j.ahj.2010.04.023. Am Heart J. 2010. PMID: 20598987 Free PMC article.
-
Medicare Part D and quality of prescription medication use in older adults.Drugs Aging. 2011 Oct 1;28(10):797-807. doi: 10.2165/11595250-000000000-00000. Drugs Aging. 2011. PMID: 21970307 Free PMC article. Review.
-
Potential impact of Medicare Part D in the end-stage renal disease population.Adv Chronic Kidney Dis. 2008 Apr;15(2):140-6. doi: 10.1053/j.ackd.2008.01.014. Adv Chronic Kidney Dis. 2008. PMID: 18334238 Review.
Cited by
-
Upper Gastrointestinal Perforations: A Possible Danger of Antibiotic Overuse.J Gastrointest Surg. 2020 Dec;24(12):2730-2736. doi: 10.1007/s11605-019-04473-w. Epub 2019 Dec 16. J Gastrointest Surg. 2020. PMID: 31845145 Free PMC article.
-
Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.Adv Ther. 2017 Aug;34(8):1976-1988. doi: 10.1007/s12325-017-0584-x. Epub 2017 Jul 13. Adv Ther. 2017. PMID: 28707284 Free PMC article.
-
Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.Clin Cardiol. 2017 Jan;40(1):38-45. doi: 10.1002/clc.22603. Epub 2016 Oct 26. Clin Cardiol. 2017. PMID: 27783884 Free PMC article.
-
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.Circ Heart Fail. 2016 Feb;9(2):e002444. doi: 10.1161/CIRCHEARTFAILURE.115.002444. Circ Heart Fail. 2016. PMID: 26867758 Free PMC article.
-
Cardiologists' Perspectives on BiDil and the Use of Race in Drug Prescribing.J Racial Ethn Health Disparities. 2022 Dec;9(6):2146-2156. doi: 10.1007/s40615-021-01153-x. Epub 2022 Feb 3. J Racial Ethn Health Disparities. 2022. PMID: 35118611
References
-
- Stevenson LW. Projecting heart failure into bankruptcy in 2012? Am Heart J. 2011; 161:1007-1011 - PubMed
-
- Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high‐impact general medical journals: a systematic sampling review. JAMA. 2007; 297:1233-1240 - PubMed
-
- Tinetti ME, Studenski SA. Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med. 2011; 364:2478-2481 - PubMed
-
- Curtis LH, Whellan DJ, Hammill BG, Hernandez AF, Anstrom KJ, Shea AM, Schulman KA. Incidence and prevalence of heart failure in elderly persons, 1994–2003. Arch Intern Med. 2008; 168:418-424 - PubMed
-
- Bonow RO, Bennett S, Casey DE, Jr, Ganiats TG, Hlatky MA, Konstam MA, Lambrew CT, Normand SL, Pina IL, Radford MJ, Smith AL, Stevenson LW, Burke G, Eagle KA, Krumholz HM, Linderbaum J, Masoudi FA, Ritchie JL, Rumsfeld JS, Spertus JAAmerican College of Cardiology, American Heart Association Task Force on Performance Measures, Heart Failure Society of America ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation. 2005; 112:1853-1887 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous